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Abstract
Background: While association studies on schizophrenia show conflicting results regarding the
importance of the regulator of the G-protein signaling 4 (RGS4) gene, recent work suggests that
RGS4 may impact on the structural and functional integrity of the prefrontal cortex. We aimed to
study associations of common RGS4 variants with prefrontal dependent cognitive performance and
schizotypy endophenotypes at the population level.
Methods: Four RGS4 single nucleotide polymorphisms (SNP1 [rs10917670], SNP4 [rs951436],
SNP7 [rs951439], and SNP18 [rs2661319]) and their haplotypes were selected. Their associations
with self-rated schizotypy (SPQ), vigilance, verbal, spatial working memory and antisaccade eye
performance were tested with regressions in a representative population of 2,243 young male
military conscripts.
Results: SNP4 was associated with negative schizotypy (higher SPQ negative factor for common
T allele, p = 0.009; p = 0.031 for differences across genotypes) and a similar trend was seen also
for common A allele of SNP18 (p = 0.039 for allele-load model; but p = 0.12 for genotype
differences). Haplotype analyses showed a similar pattern with a dose-response for the most
common haplotype (GGGG) on the negative schizotypy score with or without adjustment for age,
IQ and their interaction (p = 0.011 and p = 0.024, respectively). There was no clear evidence for
any association of the RGS4 variants with cognitive endophenotypes, except for an isolated effect
of SNP18 on antisaccade error rate (p = 0.028 for allele-load model).
Conclusion: Common RGS4 variants were associated with negative schizotypal personality traits
amongst a large cohort of young healthy individuals. In accordance with recent findings, this may
suggest that RGS4 variants impact on the functional integrity of the prefrontal cortex, thus
increasing susceptibility for psychotic spectrum disorders.
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Background
Over the past few years conflicting evidence has been
obtained concerning the association between the gene
encoding the regulator of G-protein signaling 4 (RGS4)
and schizophrenia. Initially evidence for linkage with
schizophrenia was reported near RGS4 at 1q21-22 [1,2]
and several association studies also suggested modest
associations for certain RGS4 gene variants [3-9]. How-
ever, a follow-up investigation of the original linkage
study found no associations with RGS4 in this same sam-
ple [10] and many other studies found also negative
results. Three recent meta-analyses either show no associ-
ation between RGS4 and schizophrenia or suggest modest
effects for SNP4 (rs951436) and for two common haplo-
types [11-13]. Updated evaluation of the relevant associa-
tion data shows no significant association for any of the 4
most commonly studied polymorphisms [14].
A plausible hypothesis to explain the inconsistencies in
these studies is that RGS4 variants may modulate endophe-
notypes associated with schizophrenia rather than risk of
disease itself [15]. Endophenotypes are measurable com-
ponents along the pathway between the genetic infra-
structure and the presentation of a disorder. Candidate
endophenotypes of schizophrenia with which the disor-
der presumably shares a degree of overlapping genetic lia-
bility include structural and morphometric brain
alterations, neurocognitive deficits and schizotypal per-
sonality traits or symptoms. These are expressed as quan-
titative traits with different intensities across a broad
phenotypic spectrum, ranging from patients to their unaf-
fected relatives and extending to the (disease-free) general
population. Recent evidence that RGS4 may indeed
impact on such endophenotypes is provided by. Prasad et
al [16] who reported that left dorsolateral prefrontal cor-
tex (DLPFC) volumes were significantly different across
first episode schizophrenia patients and controls on SNPs
4 (rs951436) and 18 (rs2661319) after correcting for mul-
tiple comparisons, indicating that these RGS4 polymor-
phisms may contribute to structural alterations in brain
areas, previously associated with schizophrenia. Buck-
holtz et al [17] provided further evidence that SNP 4
(rs951436) impacts frontoparietal and frontotemporal
response during working memory (n-Back test) and
regionally specific reductions in gray and white matter
structural volume in healthy individuals carrying the com-
mon risk allele. These studies indicate that structural and
functional integrity of the prefrontal cortex might be asso-
ciated with RGS4 polymorphic variation.
We have recently reported on the utility of adopting a
population endophenotype approach to study the poten-
tial effect of candidate susceptibility genes for schizophre-
nia [18]. We hypothesize that endophenotypes for
schizophrenia such as schizotypal personality traits [19],
cognitive ability dependent on the integrity of prefrontal
cortex such as sustained attention [20], working memory
[21] and antisaccade eye-movements [22], may serve as
potential targets of schizophrenia susceptibility genes. In
this study, we set out to evaluate in a large cohort of appar-
ently healthy young males whether 4 single nucleotide
polymorphic variability in the RGS4 gene locus that has
been previously associated with schizophrenia suscepti-
bility, does modulate the expression of such schizophre-
nia related endophenotypes. We specifically hypothesized
based on recent neuroimaging reports that RGS4 com-
mon "risk" alleles and haplotypes would be associated
with a relative impairment of prefrontally mediated psy-
chological and/or neuropsychological function.
Methods
Population
Details on the study population, assessments, and out-
comes have been presented previously [18]. Briefly, the
Athens Study of Psychosis Proneness and Incidence of
Schizophrenia (ASPIS) examined 2243 randomly selected
young male conscripts aged 18 to 24 years from the Greek
Air Force in their first 2 weeks of admission to the
National Basic Air Force Training Center. Conscripts
underwent an extensive interview of computerized neuro-
cognitive abilities and a self-rated psychometric evalua-
tion. After obtaining written informed consent, DNA was
extracted from mouthwash samples. This study was
approved by the Bioethics and Medical Deontology Com-
mittee of the University Mental Health Research Institute.
Assessments
The assessment battery included, among other (see
below), the Raven Progressive Matrices [23] and the
Schizotypal Personality Questionnaire (SPQ) [18,24,25].
Each subject performed cognitive tasks and eye-move-
ment tasks These included assessment of verbal and spa-
tial versions of the n-back task to assess verbal and spatial
working memory [26,27] and anti-saccade eye movement
task [28].
In this report we chose not to analyse other available pop-
ulation phenotypes that are not considered to be directly
related to prefrontal function, such as general measure of
state psychopathology, self rated personality scales, sub-
clinical psychotic symptoms (Community Assessment of
Psychic Experiences [29], and additional eye tracking
measures.
We excluded from analyses individuals whose responses
did not have face validity, based on a priori specified crite-
ria. These were a negative central index of performance in
2-back tests; three or more unsuccessful trials (out of five)
for verbal and spatial 2-back; and at least 50 invalid out of
90 antisaccade trials. We also excluded random respond-Behavioral and Brain Functions 2008, 4:46 http://www.behavioralandbrainfunctions.com/content/4/1/46
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ers in the TCI questionnaire [30], i.e., subjects who
responded incorrectly in at least one out of four validity
items.
DNA extraction, SNP selection and genotyping
Mouthwash samples for DNA extraction were chosen as
described previously [31] to obtain a better procedure
acceptance rate. For RGS4  we selected the four SNPs
reported originally by Chowdari et al [3], namely SNP1
(rs10917670), SNP4 (rs951436), SNP7 (rs951439), and
SNP18 (rs2661319). These SNPs have been assessed prac-
tically in all subsequent association studies on this gene
[11].
All genotyping was performed blind to phenotype meas-
ures by K-Biosciences [32] using a competitive allele-spe-
cific PCR system (CASP). Genotyping was conducted on
all markers and then a quality control procedure was
applied using a simple statistical exclusion protocol for
removal of poor quality DNA samples: the call rate as a
percentage of SNP's genotyped were determined on a
sample by sample basis. DNA samples that failed to call in
60% or more SNP's were excluded from the data set to
improve reliability and accuracy of the data. Regarding
inter and intra plate duplication. 5.8% of the genotyping
data was repeated both within 384 well PCR plates and
between 384 PCR plates. This repetition showed 3 non-
concordant calls indicating an error rate of < 0.1%.
Outcomes – Statistical analysis
We quantified schizotypal traits as continuous measure-
ments with the total score from the SPQ instrument. We
assessed separately the four schizotypal latent dimensions
of SPQ that emerged from applying confirmatory factor
analysis to this dataset (cognitive/perceptual, negative,
disorganization and paranoid factor) [25]. Moreover, we
measured neurocognitive performance on four tasks: sus-
tained attention, short-term spatial and verbal working
memory and antisaccade eye movements. These measures
were quantified using the corresponding sensitivity
indexes: d'-CPT_IP, d'-S2B, d'-V2B and antisaccade error
rate, respectively.
For every SNP we assessed compliance with the Hardy-
Weinberg (HW) law using an exact test. We estimated the
D' and r2 coefficients for SNP pairs using Haploview 3.2
[33]. Haplotypes (SNP1-SNP7-SNP4-SNP18) for each
gene were reconstructed with PHASE 2.1.1 [34,35]. Con-
vergence of the Markov Chain Monte Carlo chains in
PHASE was assessed by multiple (at least 5) runs. Haplo-
types with frequency < 5% were grouped in a miscellane-
ous ("rare") category.
We checked for systematic differences in genotype and
haplotype frequencies between those conscripts who were
finally eligible and those who were excluded based on
their random or incomplete questionnaire responses. Dif-
ferences in the distributions were tested with chi-squared
tests for individual SNPs and with a permutation test
implemented in PHASE for haplotypes [34].
We assessed the impact of genetic factors on phenotype
with regression models. Both single polymorphism anal-
yses and haplotype-based analyses were performed. In
single polymorphism evaluations, the distribution of each
outcome per genotypic group was assessed with analysis
of variance (ANOVA); this is a model-free approach that
does not presume a specific model of genetic effect. We
also examined with linear regressions whether the
number of minor allele copies was associated with each
outcome (allele-load or allele-based additive models). In
haplotype-based assessments, we also relied on a likeli-
hood ratio test (LR p value) to assess whether a regression
model taking into account the genetic factors provided
better fit (explained data better) than a constant only
model. In the regression models, the most common hap-
lotype was used as the reference category. This choice was
arbitrary but is mathematically equivalent to choosing
any haplotype as the reference category. In addition we
contrasted the most common haplotype against all other
haplotypes combined. Sensitivity analyses weighted each
haplotype according to its probability as calculated by
PHASE.
The main analyses did not adjust for non-genetic factors.
However, in a secondary analysis, we adjusted for age and
IQ and their interaction. In the latter case, we based infer-
ences on the presence of genetic effects by assessing with
a likelihood ratio test whether a model that takes age, IQ
and gene haplotypes into account provides better fit than
a model based on age and IQ only.
Association analyses were performed in Intercooled Stata
8.2 [36]. The reported p-values are 2-tailed and uncor-
rected for multiple comparisons.
For associations that passed the threshold of statistical sig-
nificance at the p = 0.05 level, we also estimated the
respective Bayes factors. We followed the method of Ioan-
nidis [37] where the prior is specified as a spike null and
smear alternative. The spike is placed at the null and the
smear is normally distributed around the null. The Bayes
factor can be readily estimated from the observed z-value
(standardized effect) of the associaiton, the variance of
the observed effect, and the assumed average value of the
genetic effects in a given direction under the alternative.
We applied these calculations illustratively for significant
association in the allele-based model. The inverse of the
Bayes factor shows how many times the odds that an asso-Behavioral and Brain Functions 2008, 4:46 http://www.behavioralandbrainfunctions.com/content/4/1/46
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ciation is true increases compared to the prior odds before
running the study.
Results
Descriptive data
In total, 2243 randomly selected young male conscripts
(mean age, 20.7 +- 1.90) entered the study. As previously
described in more detail [18] the proportion of conscripts
who gave eligible responses and measurements varied
between 60% for SPQ and 90% for cognitive measure-
ments.
Genotyping was successful for 81.4% on rs10917670,
88.2% on rs951436, 89.8% on rs951439, and 78.7% on
rs2661319. Genotype availability was not significantly
related to any of the instrument scores (p-values ranged
between 0.64 and 1.00 for all analyses).
Genotype frequencies were as follows. For rs10917670:
AA = 325, AG = 842, GG = 522; for rs951436 GG = 374,
GT = 927, TT = 531; for rs951439: AA = 353, AG = 949, GG
= 563; and for rs2661319: GG = 379, AG = 813, and AA =
441. No significant deviations from the HW law were seen
for any of the 4 tested polymorphisms (p > 0.19 for all).
Strong linkage disequilibrium was observed between
rs10917670 and rs951439 (r2 = 0.98). r2 values ranged
between 0.51 and 0.81 for all other SNP pairs. In accord-
ance with previous reported studies on individuals of
Caucasian origin, the most common haplotypes were
GGGG (44.0%), ATAA (40.8%), and GTGA (9.9%); all
other haplotypes occurred in 3% or less of the population.
Associations with individual SNPs – model-free approach
In model-free analyses (analyses that compare outcome
distributions across the three genotypes for each SNP) a
single association between SNP4 (rs951436) and the neg-
ative dimension of schizotypal personality reached nomi-
nal statistical significance (p = 0.031).
Associations with individual SNPs – allele-load models
As shown in Table 1, there were three nominally statisti-
cally significant signals when analyses used an additive
allele-load model. Specifically the T allele of SNP4
(rs951436) and the A allele of SNP18 were associated
with an increase in negative schizotypy (p = 0.009 and p
= 0.039, respectively). The latter was also associated with
an increase in antisaccade error rate (p = 0.028). Effect
sizes were modest for these nominally significant find-
ings. The three nominally statistically significant associa-
tions (p = 0.009, 0.039 and 0.028) had Bayes factors of
0.15, 0.43, and 0.30, respectively, when the genetic effect
under the alternative was assumed to have an average
value in the negative direction of -0.01, -0.01, and -0.02
respectively (the magnitude of the effects estimates that
were observed).
Table 1: Effect sizes (beta) per minor allele copy for RGS4 gene SNPs
rs10917670
per A allele copy
rs951436
per G allele copy
rs2661319
per G allele copy
Response Nb e t a P all-load (PANOVA) Nb e t a P all-load (PANOVA) Nb e t a P all-load (PANOVA)
IQ (RPM) 1470 -0.39 0.235 (0.349) 1595 0.17 0.603 (0.799) 1411 0.10 0.773 (0.715)
SPQ total score 1043 0.49 0.363 (0.607) 1134 -0.65 0.215 (0.455) 1004 -0.64 0.246 (0.502)
SPQ cognitive/perceptual factor 1041 0.00 0.553 (0.839) 1132 -0.00 0.807 (0.966) 1002 -0.00 0.514 (0.795)
SPQ negative factor 1041 0.01 0.184 (0.291) 1132 -0.01 0.009 (0.031) 1002 -0.01 0.039 (0.117)
SPQ disorganization factor 1041 0.01 0.256 (0.493) 1132 -0.01 0.266 (0.538) 1002 -0.01 0.262 (0.493)
SPQ paranoid factor 1041 0.00 0.980 (0.876) 1132 0.00 0.908 (0.881) 1002 0.00 0.896 (0.976)
d'-S2B (spatial working memory) 1434 -0.06 0.153 (0.352) 1558 -0.02 0.514 (0.650) 1384 -0.02 0.682 (0.900)
d'-V2B (verbal working memory) 1372 -0.05 0.124 (0.306) 1494 0.02 0.556 (0.285) 1324 0.01 0.755 (0.785)
Antisaccade error rate 1585 0.01 0.286 (0.565) 1731 -0.01 0.069 (0.173) 1532 -0.02 0.028 (0.089)
SNP, single nucleotide polymorphism; ANOVA, analysis of variance; Pall-load, p value for the allele-load model; PANOVA, ANOVA p value. Strong 
linkage disequilibrium was observed between rs10917670 and rs951439 (r2 = 0.98). Results of rs951439 are not shown but are similar to rs 
10917670.Behavioral and Brain Functions 2008, 4:46 http://www.behavioralandbrainfunctions.com/content/4/1/46
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Haplotype-based analyses
Overall, haplotype analyses yielded consistent results
with SNP-based analyses (Table 2 and Table 3). In main
analyses, likelihood ratio tests suggested a non-significant
relationship between RGS4 haplotypes and the negative
dimension of SPQ (p = 0.06; Table 2). The reference hap-
lotype GGGG (that does not include the T allele of SNP4
and the A allele of SNP18) was associated with lower val-
ues in the negative dimension of SPQ, compared to the
common ATAA and GTGA haplotypes (p = 0.03; Table 2),
or compared to all other haplotypes combined (p = 0.01;
Table 3), albeit with modest effects. In addition, non-sig-
nificant trends for a relationship of haplotypes with spa-
tial working memory were also observed (likelihood ratio
testing, p = 0.07; Table 2). Adjusted analyses were qualita-
tively similar for the aforementioned outcomes.
Weighting for the probability of each haplotype (Table 4
and Table 5) suggested a trend for an association of hap-
lotypes with spatial working memory (likelihood ratio
tests, p = 0.048 without and p = 0.077 with adjustments).
Specifically, each copy of the GTGA haplotype was associ-
ated with slightly superior spatial working memory per-
formance (0.16 points) compared to individuals with the
most common haplotype GGGG. Haplotype analyses
limited to haplotypes where all SNPs were available ver-
sus including also those where some SNPs were missing,
yielded similar results.
Discussion
Our analysis has found that RGS4 variants exhibit some
tentative signals for association with endophenotypes that
might be relevant to the pathogenesis of schizophrenia.
Common 'risk' alleles of SNP4 and SNP18, the SNPs that
have been previously related also to reduced prefrontal
cortex volume and function, were associated in the cur-
rent study with an increase in negative schizotypal person-
ality traits amongst a large population of apparently
healthy young male conscripts. Haplotype analysis gener-
ally supported this association. An isolated model-specific
effect of risk allele A (SNP18) on antisaccade error rate
was noted. The SNPs 1 and 7 that were not associated with
reduced brain volumes in a previous study [16] had no
effect on cognitive or schizotypy endophenotypes.
Negative schizotypy personality traits in the general pop-
ulation similarly to their illness counterpart (negative
symptoms in schizophrenia), are considered to be associ-
ated mostly with subtle deficits of prefrontal brain func-
tion. This is indicated by the modest but persistent
correlation of this schizotypy factor to executive dysfunc-
tion and working memory deficits [38-40]. If RGS4 vari-
ants truly contribute to structural and functional
alterations of the prefrontal cortex [16,17], the observed
association of RGS4 risk variants with negative schizotypy
may reflect such an impact on prefrontal function. Fur-
thermore, the dose effect of risk allele A of SNP18 on neg-
ative schizotypy and simultaneously on antisaccade error
Table 2: Haplotypes based on best pairs (unweighted) UNADJUSTED
Rare (< 5%) ATAA GTGA
Response N bs ebs ebs e L R  P - v a l u e
IQ (RPM) 1703 -0.626 (0.792) -0.366 (0.332) 0.265 (0.527) 0.50
SPQ total score 1211 1.214 (1.279) 0.683 (0.539) 0.424 (0.881) 0.55
SPQ cognitive/perceptual factor 1211 0.003 (0.012) 0.003 (0.005) -0.001 (0.008) 0.91
SPQ negative factor 1211 0.012 (0.013) 0.011* (0.005) 0.020* (0.009) 0.059
SPQ disorganization factor 1211 0.026 (0.021) 0.012 (0.009) 0.004 (0.014) 0.42
SPQ paranoid factor 1211 0.006 (0.019) 0.001 (0.008) -0.007 (0.013) 0.92
d'-S2B (spatial working memory) 1656 -0.047 (0.091) -0.015 (0.039) 0.146* (0.063) 0.073
d'-V2B (verbal working memory) 1583 0.017 (0.077) -0.028 (0.034) 0.015 (0.053) 0.77
Antisaccade error rate 1835 -0.023 (0.018) 0.013 (0.008) 0.013 (0.012) 0.10
The reference haplotype is GGGG
Shown are the coefficients of a regression model/copy of the corresponding haplotype. b, coefficient, expressing change in the response variable/
haplotype copy; SE, standard error of the coefficient b; LR p value, p value for a likelihood ratio test against a constant-only model;
* significantly different (p < 0.05) from the reference haplotype GGGG (the most common in the population).Behavioral and Brain Functions 2008, 4:46 http://www.behavioralandbrainfunctions.com/content/4/1/46
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Table 3: Most Common haplotype vs all other haplotypes based on best pairs (unweighted)
UNADJUSTED ADJUSTED for IQ age and interaction thereof
Per GGGG copy Per GGGG copy
Response N bs e L R  P - v a l u e N bs e L R  P - v a l u e
IQ (RPM) 1703 0.262 (0.310) 0.40
SPQ total score 1211 -0.677 (0.503) 0.18 1203 -0.535 (0.502) 0.29
SPQ cognitive/perceptual factor 1211 -0.002 (0.005) 0.63 1203 -0.001 (0.005) 0.87
SPQ negative factor 1211 -0.013* (0.005) 0.011 1203 -0.011* (0.005) 0.024
SPQ disorganization factor 1211 -0.012 (0.008) 0.16 1203 -0.009 (0.008) 0.26
SPQ paranoid factor 1211 0.000 (0.008) 0.99 1203 0.001 (0.008) 0.87
d'-S2B (spatial working memory) 1656 -0.012 (0.036) 0.74 1462 -0.045 (0.033) 0.18
d'-V2B (verbal working memory) 1583 0.016 (0.031) 0.60 1394 -0.004 (0.029) 0.88
Antisaccade error rate 1835 -0.010 (0.007) 0.15 1622 -0.004 (0.007) 0.60
Shown are the coefficients of a regression model/copy of the corresponding haplotype. b, coefficient, expressing change in the response variable/
haplotype copy; SE, standard error of the coefficient b; LR p value, p value for a likelihood ratio test against a constant-only model.
* significantly different (p < 0.05) from the reference haplotype GGGG (the most common in the population).
Table 4: Haplotypes weighting for the probability of each haplotype UNADJUSTED
Rare (< 5%) ATAA GTGA
Response N bs ebs ebS e L R  P - v a l u e
IQ (RPM) 1703 -0.643 (0.794) -0.351 (0.335) 0.314 (0.539) 0.49
SPQ total score 1211 1.322 (1.281) 0.657 (0.545) 0.421 (0.900) 0.54
SPQ cognitive/perceptual factor 1211 0.004 (0.012) 0.003 (0.005) -0.001 (0.008) 0.92
SPQ negative factor 1211 0.013 (0.013) 0.011* (0.005) 0.020* (0.009) 0.061
SPQ disorganization factor 1211 0.028 (0.021) 0.011 (0.009) 0.004 (0.015) 0.40
SPQ paranoid factor 1211 0.007 (0.019) 0.001 (0.008) -0.008 (0.014) 0.91
d'-S2B (spatial working memory) 1656 -0.049 (0.091) -0.014 (0.039) 0.161* (0.065) 0.048
d'-V2B (verbal working memory) 1583 0.022 (0.077) -0.029 (0.034) 0.020 (0.055) 0.72
Antisaccade error rate 1835 -0.021 (0.018) 0.013 (0.008) 0.013 (0.012) 0.12Behavioral and Brain Functions 2008, 4:46 http://www.behavioralandbrainfunctions.com/content/4/1/46
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rate (arguably a good index of Dorsolateral Prefrontal
Cortex integrity) provides some further support to the
notion that RGS4 risk variants are associated with subtle
deficits at the information processing level surveyed by
the prefrontal cortex. A similar pleiotropic effect of SNP4
on negative psychotic symptoms and tasks dependant on
the integrity of prefrontal function (verbal fluency) was
also noted in a recent association study [9] although these
associations did not survive multiple comparison testing.
On the other hand, we observed no clear effect of RGS4
polymorphisms on 2- Back working memory indices of
performance as in a recent study [17], but nevertheless
haplotype analyses offered a soft signal of association
with spatial working memory.
RGS4 variation was associated with negative rather than
positive schizotypy. These two factors may have relatively
independent neurocognitive [40] neurochemical [41] and
genetic [42,43] underpinnings. Negative symptoms in
schizophrenia lay in an etiological continuum with their
personality counterpart [44] and may have greater famil-
iar, neurodevelopmental and possibly genetic basis than
positive ones. Interestingly the first emerging association
studies which include clinical and neurocognitive out-
comes, also suggest associations of SNP4 or SNP18 with
PANSS global psychopathology scores [9,45], negative
PANSS symptoms and simultaneous association with
tasks dependent of prefrontal brain function (verbal flu-
ency) and impaired neurodevelopment (premorbid ver-
bal IQ) [9].
If RGS4 variation has only modest effects on negative
schizotypy endophenotypes, as observed in our study, this
may explain the inconsistency of the previous association
studies and the lack of a demonstrable strong association
with schizophrenia per se, when these studies have been
combined in meta-analyses [14]. Depending on the pop-
ulation mix and the importance that these endopheno-
types may play in the disease process, some case-control
studies of schizophrenia may show subtle effects with
RGS4  variants, while others may show none. Genetic
effects on schizophrenia risk may be very small on average
and may require thousands of several tens of thousands of
subjects to document or refute convincingly [46]. Con-
versely, quantitative traits such as these endophenotypes
would be possible to study efficiently with relatively
smaller sample sizes. Still, the importance of replicating
our results in other cohorts cannot be over-emphasize
[47,48]. Conclusive results are likely to require considera-
ble sample sizes even for these endophenotypes, and in
the presence of population or other heterogeneity, con-
sistent replication may be difficult [49].
Along these lines, we acknowledge that, several, if not all,
of the identified signals in our study might be false posi-
tives [50,51]. With 4 SNPs and 10 outcome variables,
there are 40 sets of analyses performed, even without con-
sideration of haplotypes. However, 2 SNPs were in almost
perfect linkage disequilibrium and many of the outcomes
also show high correlation with each other. Therefore, the
multiplicity of comparisons is far less than implied at first
Table 5: Haplotypes weighting for the probability of each haplotype ADJUSTED for age, IQ and interaction
Rare (< 5%) ATAA GTGA
Response N bs ebs ebs e L R  P - v a l u e
SPQ total score 1203 0.741 (1.290) 0.510 (0.543) 0.517 (0.895) 0.77
SPQ cognitive/perceptual factor 1203 -0.001 (0.012) 0.001 (0.005) -0.001 (0.008) 0.99
SPQ negative factor 1203 0.005 (0.013) 0.009 (0.005) 0.021* (0.009) 0.071
SPQ disorganization factor 1203 0.018 (0.021) 0.009 (0.009) 0.005 (0.015) 0.67
SPQ paranoid factor 1203 0.003 (0.019) -0.001 (0.008) -0.007 (0.014) 0.95
d'-S2B (spatial working memory) 1462 0.124 (0.085) 0.018 (0.036) 0.135* (0.059) 0.077
d'-V2B (verbal working memory) 1394 0.053 (0.073) -0.004 (0.032) 0.017 (0.051) 0.87
Antisaccade error rate 1622 -0.025 (0.019) 0.008 (0.008) 0.002 (0.013) 0.35
The reference haplotype is GGGG. Shown are the coefficients of a regression model/copy of the corresponding haplotype. b, coefficient, expressing 
change in the response variable/haplotype copy; SE, standard error of the coefficient b; LR p value, p value for a likelihood ratio test against a 
constant-only model;
* significantly different (p < 0.05) from the reference haplotype GGGG (the most common in the population).Behavioral and Brain Functions 2008, 4:46 http://www.behavioralandbrainfunctions.com/content/4/1/46
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sight. Moreover, our approach was to target variants of a
gene that already had some indirect or direct support for
involvement in the pathogenesis of schizophrenia and
therefore the pre-study probability of significant associa-
tions was not negligible as in a hypothesis-free, discovery-
oriented approach. Regardless, the interpretation of the
modestly significant associations should be conservative.
In addition, the Bayes factors obtained for the nominally
significant associations are not very strong, but they
should not be disregarded, given the prior evidence on
potential implication of this genes and variants in related
phenotypes.
We should also acknowledge that observed associations
may exist due to hitherto unidentified risk variants at
RGS4 that are in strong linkage disequilibrium with these
four SNPs. All four SNPs in the associated haplotype are
non-coding SNPs, but SNPs 1, 4 and 7 are located in a 5'
region of the gene that may play a role in transcription
regulation.
Another limitation of our study was the considerable rate
of non-responders for some items, especially the Schizo-
typal Personality Questionnaire and the loss of some
information due to failure of genotyping in some mouth-
wash samples. These missing data may have eroded some
of the power of the study to detect statistically significant
genetic effects. However, there is no reason why genotypes
would be missed preferentially in participants with spe-
cific phenotypes and indeed we found no hint of such
association. Similarly, we found no evidence that pheno-
type data were missing based on phenotype. Therefore,
missing data is unlikely to have generated false-positives.
Conclusion
Allowing for these caveats, our study suggests that SNP4
and SNP18 may affect some yet unidentified prefrontal-
mediated neuronal mechanism that predisposes appar-
ently healthy individuals to report higher scores on items
related to social isolation, and interpersonal difficulties.
These genetic effects seem to be modest, but they are def-
initely worth of further evaluation, since they would per-
tain to the wide general population of otherwise healthy
individuals.
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